Best Sevabertinib (Hyrnuo) Medicine in India

Sevabertinib (Hyrnuo) is a targeted anticancer treatment used to treat adults with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have specific HER2 (ERBB2) tyrosine kinase domain activating mutations and who have received prior systemic therapy. It belongs to a group of medicines called kinase inhibitors and works by blocking abnormal HER2 signaling involved in cancer-cell growth and survival, helping to slow disease progression.

Sevabertinib (Hyrnuo) should be taken exactly as prescribed by your doctor. It is taken orally with food according to the recommended treatment schedule. Swallow it whole with water and do not crush, chew, or break it. Regular medical check-ups and laboratory tests may be required to monitor your response to treatment, liver function, and overall health.

Common side effects of Sevabertinib (Hyrnuo) may include diarrhea, rash, nail changes, mouth sores, nausea, decreased appetite, fatigue, muscle or joint pain, and changes in liver or pancreatic enzyme levels. Sevabertinib may also cause serious lung, liver, eye, or pancreatic problems in some patients. Inform your doctor promptly if you develop breathing difficulties, persistent cough, severe diarrhea, vision changes, or other concerning symptoms. Before starting treatment, tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking.

Treatment of HER2-Mutated Non-Small Cell Lung Cancer

Sevabertinib (Hyrnuo) is used to treat adults with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with specific activating HER2 (ERBB2) tyrosine kinase domain mutations who have received prior systemic therapy. It blocks abnormal HER2 signaling, helping to slow cancer-cell growth and disease progression.

Some side effects of Sevabertinib (Hyrnuo) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Sevabertinib (Hyrnuo)

Take Sevabertinib (Hyrnuo) exactly as prescribed by your doctor, usually once daily with food. Take it at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. Follow your doctor's instructions if you miss a dose or vomit after taking it. Continue treatment as recommended and attend regular medical check-ups and laboratory tests.

Sevabertinib (Hyrnuo) is a HER2 tyrosine kinase inhibitor that targets specific activating HER2 (ERBB2) mutations in cancer cells. It blocks abnormal HER2 signaling involved in cancer-cell growth and survival, helping to inhibit tumor growth and slow disease progression.

AlcoholCONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as nausea, fatigue, or dizziness. Follow your doctor's advice.

PregnancyCONSULT YOUR DOCTOR

Hyrnuo may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the effects on a breastfed child are not fully known.

DrivingCONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience fatigue, dizziness, vision changes, or other effects that may impair your alertness.

KidneyCAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function and provide appropriate medical care during treatment.

LiverCAUTION

Tell your doctor about any liver condition. Regular liver function tests may be required, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.